Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhimin Shao

Showing results (91-100 of 203) with videos related to

Pageof 21
Sort By:
Zhonghua Yi Xue Za Zhi|April 16, 2014
[Prediction value for dynamic changes of circulating tumor cell in therapeutic response and prognosis of Chinese metastatic breast cancer patients]Li Bian, Yi Liu, Tao Wang, et al.
Clinical & Experimental Metastasis|March 20, 2013
Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesisLi Wang, Shaoxian Tang, Yingjian Wang, et al.
Journal of Cancer Research and Clinical Oncology|August 3, 2007
Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cellsLi Wang, Xuerui Zhou, Tingting Zhou, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 27, 2018
Treatment patterns for adjuvant docetaxel-based chemotherapy in early-stage breast cancer in China: A pooled retrospective analysis of four observational studiesBinghe Xu, Zhimin Shao, Shui Wang, et al.
Oncotargets and Therapy|April 20, 2018
Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II-III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomyXingxing Chen, Fan Xia, Jurui Luo, et al.
Cancer Biology & Therapy|February 5, 2015
A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancerJian Zhang, Leiping Wang, Zhonghua Wang, et al.
Frontiers in Oncology|November 17, 2022
Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective studyYuting Sang, Xujie Zhou, Weiru Chi, et al.
Frontiers in Radiology|July 16, 2026
Early identification of PRISm from chest CT: a multimodal for three-class stratification of normal, PRISm, and COPDYan Mou, Xueqing Bian, Na Tian, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|December 15, 2015
[Germline mutations of TP53 gene among Chinese families with high risk for breast cancer]Xiaochen Yang, Zhen Hu, Jiong Wu, et al.
Medicine|May 26, 2018
Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa studyJunjie Li, Zhimin Shao, Binghe Xu, et al.
Pageof 21

Showing results (91-100 of 203) with videos related to

Sort By:
Pageof 21
Zhonghua Yi Xue Za Zhi|April 16, 2014
[Prediction value for dynamic changes of circulating tumor cell in therapeutic response and prognosis of Chinese metastatic breast cancer patients]Li Bian, Yi Liu, Tao Wang, et al.
Clinical & Experimental Metastasis|March 20, 2013
Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesisLi Wang, Shaoxian Tang, Yingjian Wang, et al.
Journal of Cancer Research and Clinical Oncology|August 3, 2007
Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cellsLi Wang, Xuerui Zhou, Tingting Zhou, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 27, 2018
Treatment patterns for adjuvant docetaxel-based chemotherapy in early-stage breast cancer in China: A pooled retrospective analysis of four observational studiesBinghe Xu, Zhimin Shao, Shui Wang, et al.
Oncotargets and Therapy|April 20, 2018
Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II-III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomyXingxing Chen, Fan Xia, Jurui Luo, et al.
Cancer Biology & Therapy|February 5, 2015
A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancerJian Zhang, Leiping Wang, Zhonghua Wang, et al.
Frontiers in Oncology|November 17, 2022
Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective studyYuting Sang, Xujie Zhou, Weiru Chi, et al.
Frontiers in Radiology|July 16, 2026
Early identification of PRISm from chest CT: a multimodal for three-class stratification of normal, PRISm, and COPDYan Mou, Xueqing Bian, Na Tian, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|December 15, 2015
[Germline mutations of TP53 gene among Chinese families with high risk for breast cancer]Xiaochen Yang, Zhen Hu, Jiong Wu, et al.
Medicine|May 26, 2018
Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa studyJunjie Li, Zhimin Shao, Binghe Xu, et al.
Pageof 21